HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49224,
"recordsTotal": 49224,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=44700",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=44100",
"results": [
{
"registry_id": "NCT03900429",
"publication_url": "https://clinicaltrials.gov/study/NCT03900429",
"title": "A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (Resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation",
"has_exemption": true,
"start_date": "2019-03-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madrigal Pharmaceuticals, Inc.",
"sponsor_slug": "madrigal-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03794076",
"publication_url": "https://clinicaltrials.gov/study/NCT03794076",
"title": "Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia",
"has_exemption": false,
"start_date": "2019-04-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vishwajit Nimgaonkar, MD PhD",
"sponsor_slug": "vishwajit-nimgaonkar-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05215132",
"publication_url": "https://clinicaltrials.gov/study/NCT05215132",
"title": "Study Evaluation of Feasibility and Reproducibility of Investigational MRI Clinical Software",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04436042",
"publication_url": "https://clinicaltrials.gov/study/NCT04436042",
"title": "MyHand 2: An Active Hand Orthosis for Stroke Patients",
"has_exemption": false,
"start_date": "2020-03-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04136353",
"publication_url": "https://clinicaltrials.gov/study/NCT04136353",
"title": "DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer",
"has_exemption": false,
"start_date": "2020-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04414475",
"publication_url": "https://clinicaltrials.gov/study/NCT04414475",
"title": "A Phase 2b, Open-label, Multi-arm Clinical Trial of Selinexor Plus Low-dose Dexamethasone (Sd) in Patients With Penta-refractory Multiple Myeloma or Selinexor and Bortezomib Plus Low-dose Dexamethasone (SVd) in Patients With Triple-class Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04643366",
"publication_url": "https://clinicaltrials.gov/study/NCT04643366",
"title": "Phase 2 Study of Total Neoadjuvant mFOLFOX and Short-Course Radiotherapy in Resectable Rectal Cancer",
"has_exemption": false,
"start_date": "2021-01-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04457596",
"publication_url": "https://clinicaltrials.gov/study/NCT04457596",
"title": "The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685590",
"publication_url": "https://clinicaltrials.gov/study/NCT04685590",
"title": "Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05127954",
"publication_url": "https://clinicaltrials.gov/study/NCT05127954",
"title": "A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)",
"has_exemption": false,
"start_date": "2022-01-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313191",
"publication_url": "https://clinicaltrials.gov/study/NCT05313191",
"title": "Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors",
"has_exemption": false,
"start_date": "2022-01-24",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The New York Proton Center",
"sponsor_slug": "the-new-york-proton-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05504252",
"publication_url": "https://clinicaltrials.gov/study/NCT05504252",
"title": "METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin",
"has_exemption": false,
"start_date": "2022-10-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Akershus",
"sponsor_slug": "university-hospital-akershus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04105270",
"publication_url": "https://clinicaltrials.gov/study/NCT04105270",
"title": "A Randomized Double Blind Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination With Durvalumab (MEDI4736) and Chemotherapy in Untreated Patients With Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04936854",
"publication_url": "https://clinicaltrials.gov/study/NCT04936854",
"title": "Prospective Comparison of Sirolimus Against Corticosteroids in Treatment of Patients With Active Thyroid Eye Disease",
"has_exemption": false,
"start_date": "2023-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Haukeland University Hospital",
"sponsor_slug": "haukeland-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05699343",
"publication_url": "https://clinicaltrials.gov/study/NCT05699343",
"title": "Surgical Treatment of Peri-implantitis Using a Bone Substitute With or Without a Resorbable Collagen Membrane. A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrea Ravida",
"sponsor_slug": "andrea-ravida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05664789",
"publication_url": "https://clinicaltrials.gov/study/NCT05664789",
"title": "Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: A Randomized, Controlled Trial",
"has_exemption": false,
"start_date": "2023-04-26",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05452564",
"publication_url": "https://clinicaltrials.gov/study/NCT05452564",
"title": "Phase II Study to Evaluate the Efficacy and Safety of Baricitinib for Reduction of HIV in the Central Nervous System",
"has_exemption": false,
"start_date": "2023-05-18",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "William Tyor",
"sponsor_slug": "william-tyor",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764733",
"publication_url": "https://clinicaltrials.gov/study/NCT05764733",
"title": "The Bone, Exercise, Alendronate, and Caloric Restriction Trial",
"has_exemption": false,
"start_date": "2023-06-08",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985655",
"publication_url": "https://clinicaltrials.gov/study/NCT05985655",
"title": "A Phase 1/2 Open-label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of GTAEXS617 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-07-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.",
"sponsor_slug": "exscientia-ai-ltd-a-wholly-owned-subsidiary-of-recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05746208",
"publication_url": "https://clinicaltrials.gov/study/NCT05746208",
"title": "A Phase II Study of Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2023-07-17",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05867251",
"publication_url": "https://clinicaltrials.gov/study/NCT05867251",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-021 as a Single Agent and in Combination Therapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05988710",
"publication_url": "https://clinicaltrials.gov/study/NCT05988710",
"title": "Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia",
"has_exemption": false,
"start_date": "2023-10-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06159673",
"publication_url": "https://clinicaltrials.gov/study/NCT06159673",
"title": "A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05872204",
"publication_url": "https://clinicaltrials.gov/study/NCT05872204",
"title": "A Phase II, Open-label, Multicenter Study of Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06101342",
"publication_url": "https://clinicaltrials.gov/study/NCT06101342",
"title": "A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate the Pharmacokinetics and Safety of Twice Yearly Long-Acting Subcutaneous Lenacapavir for Pre-Exposure Prophylaxis in People Who Inject Drugs",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06106295",
"publication_url": "https://clinicaltrials.gov/study/NCT06106295",
"title": "Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06190899",
"publication_url": "https://clinicaltrials.gov/study/NCT06190899",
"title": "A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2024-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Celcuity, Inc.",
"sponsor_slug": "celcuity-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06192758",
"publication_url": "https://clinicaltrials.gov/study/NCT06192758",
"title": "An Early Feasibility Study to Evaluate the Safety of the TheraSphere Prostate Cancer (PCa) Device in Patients With Clinically Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05419492",
"publication_url": "https://clinicaltrials.gov/study/NCT05419492",
"title": "ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Infants and Children With SCN1A-Positive Dravet Syndrome",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Encoded Therapeutics",
"sponsor_slug": "encoded-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06240312",
"publication_url": "https://clinicaltrials.gov/study/NCT06240312",
"title": "Optic Nerve Head Strain as Biomarker for Glaucoma",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05968664",
"publication_url": "https://clinicaltrials.gov/study/NCT05968664",
"title": "Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashwin Viswanathan",
"sponsor_slug": "ashwin-viswanathan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544733",
"publication_url": "https://clinicaltrials.gov/study/NCT06544733",
"title": "An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically Suppressed People With HIV-1",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696366",
"publication_url": "https://clinicaltrials.gov/study/NCT05696366",
"title": "Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525220",
"publication_url": "https://clinicaltrials.gov/study/NCT06525220",
"title": "A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Recurrent or Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus B.V.",
"sponsor_slug": "merus-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06240754",
"publication_url": "https://clinicaltrials.gov/study/NCT06240754",
"title": "A Pilot Study of Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2: A Decentralized Trial",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494631",
"publication_url": "https://clinicaltrials.gov/study/NCT06494631",
"title": "Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xeltis",
"sponsor_slug": "xeltis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027099",
"publication_url": "https://clinicaltrials.gov/study/NCT06027099",
"title": "Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Surgery",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06763315",
"publication_url": "https://clinicaltrials.gov/study/NCT06763315",
"title": "The Efficacy, Safety, and Long-Term Prognosis of Low-Dose Selumetinib in the Treatment of Neurofibromatosis Type 1 Associated Plexiform Neurofibromas in Chinese Children: a Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West China Hospital",
"sponsor_slug": "west-china-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807359",
"publication_url": "https://clinicaltrials.gov/study/NCT06807359",
"title": "Open-label Clinical Phase 1/2 Study to Assess the Safety and Efficacy of the SpectraCure P18 System and Verteporfin for Injection for the Treatment of Primary Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SpectraCure AB",
"sponsor_slug": "spectracure-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773195",
"publication_url": "https://clinicaltrials.gov/study/NCT06773195",
"title": "A Phase 1/2 Study of Combined JAK/ERK Inhibition in Patients With Myelofibrosis",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504381",
"publication_url": "https://clinicaltrials.gov/study/NCT06504381",
"title": "A Phase I/IIa Study to Evaluate the Efficacy of DB107-RRV (Formerly Toca511), Administered to Subjects at Time of Resection and Intravenously Thereafter, in Combination With DB107-FC (Formerly Toca FC) and Radiation Therapy or DB107-FC, Temozolomide (TMZ) and Radiation Therapy in Patients With Newly Diagnosed High Grade Glioma",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315881",
"publication_url": "https://clinicaltrials.gov/study/NCT06315881",
"title": "Informing Oral Nicotine Pouch Regulations to Promote Public Health",
"has_exemption": false,
"start_date": "2025-01-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University Comprehensive Cancer Center",
"sponsor_slug": "ohio-state-university-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743126",
"publication_url": "https://clinicaltrials.gov/study/NCT06743126",
"title": "A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immatics US, Inc.",
"sponsor_slug": "immatics-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765317",
"publication_url": "https://clinicaltrials.gov/study/NCT06765317",
"title": "Optimizing Frontline Therapy for DLBCL in Older Adults: A GLOfitamab-based, Response-adapted, Window-stYle Study (GLORY)",
"has_exemption": false,
"start_date": "2025-01-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726122",
"publication_url": "https://clinicaltrials.gov/study/NCT06726122",
"title": "Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment for Facial, Submental and Neck Laxity",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06478017",
"publication_url": "https://clinicaltrials.gov/study/NCT06478017",
"title": "Belatacept With Delayed Tacrolimus Withdrawal Versus Standard-of-Care Tacrolimus in Heart Transplant Recipients (RTB-013)",
"has_exemption": false,
"start_date": "2025-01-29",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672575",
"publication_url": "https://clinicaltrials.gov/study/NCT06672575",
"title": "A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854653",
"publication_url": "https://clinicaltrials.gov/study/NCT06854653",
"title": "An Open-Label, Phase 2 Study of PTX-100 Monotherapy in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.",
"has_exemption": false,
"start_date": "2025-03-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prescient Therapeutics, Ltd.",
"sponsor_slug": "prescient-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470282",
"publication_url": "https://clinicaltrials.gov/study/NCT06470282",
"title": "EV-PRIME: Phase Ib/II Study of Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy as a Bladder-Sparing Trimodality Therapy in Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710756",
"publication_url": "https://clinicaltrials.gov/study/NCT06710756",
"title": "A Phase I/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients With Solid Tumors That Are Known to be Fibroblast Activation Protein (FAP)-Positive",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822426",
"publication_url": "https://clinicaltrials.gov/study/NCT06822426",
"title": "A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, Controlled, Adaptive Study To Demonstrate The Safety And Efficacy Of DEFENCATH® In Reducing Central Line-Associated Bloodstream Infections (CLABSIs) In Adult Participants Receiving Total Parenteral Nutrition (TPN) Via Central Venous Catheter (CVC)",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CorMedix",
"sponsor_slug": "cormedix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06382272",
"publication_url": "https://clinicaltrials.gov/study/NCT06382272",
"title": "Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128602",
"publication_url": "https://clinicaltrials.gov/study/NCT07128602",
"title": "Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction.",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcadia University",
"sponsor_slug": "arcadia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699836",
"publication_url": "https://clinicaltrials.gov/study/NCT06699836",
"title": "A Phase Two Study Evaluating Two Doses of Leronlimab (PRO 140) In Combination With Trifluridine + Tipiracil (TAS-102) + Bevacizumab in Participants With Microsatellite Stable (MSS), Relapsed Refractory Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2025-06-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CytoDyn, Inc.",
"sponsor_slug": "cytodyn-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991114",
"publication_url": "https://clinicaltrials.gov/study/NCT06991114",
"title": "An Open-label Phase 2a Study to Evaluate the Safety and Efficacy of AlloNK®, an Allogeneic Cord Blood-derived NK Cell Therapy, in Combination With Rituximab in Relapsing Forms of B-cell Dependent Rheumatologic Diseases",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Artiva Biotherapeutics, Inc.",
"sponsor_slug": "artiva-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973668",
"publication_url": "https://clinicaltrials.gov/study/NCT06973668",
"title": "A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148128",
"publication_url": "https://clinicaltrials.gov/study/NCT07148128",
"title": "An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumour Activity of WEF-001 in Participants With Advanced KRAS- Mutant Solid Tumours.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Auricula Biosciences Inc.",
"sponsor_slug": "auricula-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07384689",
"publication_url": "https://clinicaltrials.gov/study/NCT07384689",
"title": "MiAMII Study - Microdialysis Acquired SaMpling of Ischemia, Inflammation and Antibiotics Locally in Amputation Stump: A Comparative Study in Diabetic and Non-Diabetic Patients Undergoing Non-Traumatic Transfemoral Amputation",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Aarhus",
"sponsor_slug": "university-of-aarhus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954831",
"publication_url": "https://clinicaltrials.gov/study/NCT06954831",
"title": "Phase 2 Trial of Ultra-Hypofractionated Whole Breast Irradiation With Concomitant Lumpectomy Cavity Boost",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05361915",
"publication_url": "https://clinicaltrials.gov/study/NCT05361915",
"title": "A Phase 2 Study of AbiVERtinib in Combination With Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (Maverick Trial)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sorrento Therapeutics, Inc.",
"sponsor_slug": "sorrento-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801015",
"publication_url": "https://clinicaltrials.gov/study/NCT06801015",
"title": "A Randomized, Placebo-Controlled Trial of the Effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastric Motor Functions",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221500",
"publication_url": "https://clinicaltrials.gov/study/NCT07221500",
"title": "A Single-arm, Phase 2, Open-label, Multicenter Study to Evaluate NX-5948 in Adults With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Previously Exposed to a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a B-cell Lymphoma-2 Inhibitor (BCL-2i)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107204",
"publication_url": "https://clinicaltrials.gov/study/NCT07107204",
"title": "A Multicenter, Open-label, Single-arm Phase Ib/IIa Clinical Study to Evaluate the Safety and Efficacy of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biotroy Therapeutics",
"sponsor_slug": "biotroy-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107971",
"publication_url": "https://clinicaltrials.gov/study/NCT07107971",
"title": "Drug-Eluting Balloon Treatment Versus Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",
"sponsor_slug": "academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914765",
"publication_url": "https://clinicaltrials.gov/study/NCT06914765",
"title": "A Pilot Study Evaluating the Safety and Efficacy of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adolescents",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283822",
"publication_url": "https://clinicaltrials.gov/study/NCT07283822",
"title": "A Phase II Trial of JAK Inhibitor Added to Immunotherapy for Treatment of Relapsed/Refractory T-cell Lymphoma and 9p Amplified Lymphomas",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seda S. Tolu",
"sponsor_slug": "seda-s-tolu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07353905",
"publication_url": "https://clinicaltrials.gov/study/NCT07353905",
"title": "Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282600",
"publication_url": "https://clinicaltrials.gov/study/NCT07282600",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265479",
"publication_url": "https://clinicaltrials.gov/study/NCT07265479",
"title": "A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Organon and Co",
"sponsor_slug": "organon-and-co",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220304",
"publication_url": "https://clinicaltrials.gov/study/NCT07220304",
"title": "CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corazon Medical PC",
"sponsor_slug": "corazon-medical-pc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223892",
"publication_url": "https://clinicaltrials.gov/study/NCT07223892",
"title": "A Prospective Controlled Trial Evaluating the Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds: A Stratified Analysis by Wound Etiology and Care Setting",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bardia Anvar",
"sponsor_slug": "bardia-anvar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300852",
"publication_url": "https://clinicaltrials.gov/study/NCT07300852",
"title": "The Effectiveness of DSLT in Asian Normal Tension Glaucoma Patients",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ngoc Nguyen Inc.",
"sponsor_slug": "ngoc-nguyen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07354711",
"publication_url": "https://clinicaltrials.gov/study/NCT07354711",
"title": "A Phase I/II Study of 3H-10000 (an Anti-FGFR2b Antibody-Drug Conjugate) in Subjects With Unresectable or Metastatic Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-01-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "3H Pharmaceuticals Co., Ltd.",
"sponsor_slug": "3h-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392242",
"publication_url": "https://clinicaltrials.gov/study/NCT07392242",
"title": "A Phase II Study of IDH1 Inhibition With Ivosidenib as Maintenance Therapy After Ivosidenib, Azacitidine, and Venetoclax for Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308964",
"publication_url": "https://clinicaltrials.gov/study/NCT07308964",
"title": "A Comparative Study of Shortened (4-Infusion) Versus Standard (8-Infusion) Teprotumumab Regimens in Patients With Thyroid Eye Disease (TED) Exhibiting an Early Optimal Clinical Response",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sheba Medical Center",
"sponsor_slug": "sheba-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430085",
"publication_url": "https://clinicaltrials.gov/study/NCT07430085",
"title": "Postoperative Pain Outcomes After Use of Bupivacaine-Meloxicam Extended-Release Solution in Robot Assisted Total Knee Arthroplasty: A Prospective Study",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
"sponsor_slug": "allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214597",
"publication_url": "https://clinicaltrials.gov/study/NCT07214597",
"title": "NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE): A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217678",
"publication_url": "https://clinicaltrials.gov/study/NCT07217678",
"title": "Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369089",
"publication_url": "https://clinicaltrials.gov/study/NCT07369089",
"title": "KETAMORE: TARGETING TREATMENT-RESISTANT OUD WITH KETAMINE-ASSISTED MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07397611",
"publication_url": "https://clinicaltrials.gov/study/NCT07397611",
"title": "PRE-surgical NEOadjuvant Sandwich Immunotherapy With HIF inhibiTion in Renal Cell Carcinoma (PRENEOSHIFT-RCC)",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387367",
"publication_url": "https://clinicaltrials.gov/study/NCT07387367",
"title": "A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir Versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SymBio Pharmaceuticals",
"sponsor_slug": "symbio-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07432633",
"publication_url": "https://clinicaltrials.gov/study/NCT07432633",
"title": "A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Blue Earth Diagnostics",
"sponsor_slug": "blue-earth-diagnostics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07406360",
"publication_url": "https://clinicaltrials.gov/study/NCT07406360",
"title": "A Phase 3a, Observer Blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Combined Measles, Mumps, Rubella, and Varicella Vaccine Compared With Intramuscular Administration of ProQuad When Administered as a Second Dose to Healthy Children Aged 15 Months to 6 Years of Age",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303777",
"publication_url": "https://clinicaltrials.gov/study/NCT07303777",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics (PopPK) Profile of ABP-745 in Patients With Atherosclerosis",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Atom Therapeutics Co., Ltd",
"sponsor_slug": "atom-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07500311",
"publication_url": "https://clinicaltrials.gov/study/NCT07500311",
"title": "A Comparison of MED-EL Automatic Sound Management Features for Enhancing Speech Understanding in Noise",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Med-El Corporation",
"sponsor_slug": "med-el-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06738368",
"publication_url": "https://clinicaltrials.gov/study/NCT06738368",
"title": "Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) ± Rituximab + Recombinant Erwinia Asparaginase (JZP458; Rylaze®) for the Treatment of Newly-Diagnosed Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Lymphoma/Leukemia",
"has_exemption": false,
"start_date": "2026-05-08",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284511",
"publication_url": "https://clinicaltrials.gov/study/NCT07284511",
"title": "Fully Closed-Loop Glucose Control in Adults With Type 1 Diabetes Using Tirzepatide: a Randomized, Multi-center, Open-label, Non-inferiority, Parallel Trial",
"has_exemption": false,
"start_date": "2026-05-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "McGill University Health Centre/Research Institute of the McGill University Health Centre",
"sponsor_slug": "mcgill-university-health-centreresearch-institute-of-the-mcgill-university-health-centre",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228039",
"publication_url": "https://clinicaltrials.gov/study/NCT07228039",
"title": "A Double-Blind Prospective RCT Assessment of ESP Blocks for Analgesia Following Posterior Spinal Fusion",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322133",
"publication_url": "https://clinicaltrials.gov/study/NCT07322133",
"title": "Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07605247",
"publication_url": "https://clinicaltrials.gov/study/NCT07605247",
"title": "TREAT-EC (Tirzepatide in the Treatment of Endometrial Cancer) A Phase II Pilot Clinical Trial.",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282340",
"publication_url": "https://clinicaltrials.gov/study/NCT07282340",
"title": "Phentermine's Impact on Treatment in Teens (PhITT): A Randomized Placebo-Controlled Trial of Phentermine for Adolescents With Obesity",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Russell McCulloh, MD",
"sponsor_slug": "russell-mcculloh-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459634",
"publication_url": "https://clinicaltrials.gov/study/NCT07459634",
"title": "A Phase 2, Multicenter, Open-Label, Single-Arm Study of Lurbinectedin in Combination With Durvalumab as First-line Maintenance Therapy in Participants With Extensive-Stage Small-Cell Lung Cancer Following Induction Treatment With Platinum Based Chemotherapy and Durvalumab",
"has_exemption": false,
"start_date": "2026-06-12",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07448038",
"publication_url": "https://clinicaltrials.gov/study/NCT07448038",
"title": "A Phase IIa, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Selnoflast in Reducing Vascular Inflammation in Patients With Atherosclerosis at Risk for Major Adverse Cardiac Events",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05652478",
"publication_url": "https://clinicaltrials.gov/study/NCT05652478",
"title": "Early Metabolic Effects of Antiretroviral Drugs in Healthy Volunteers: A Phase 2 Randomized Study",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247006",
"publication_url": "https://clinicaltrials.gov/study/NCT07247006",
"title": "Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124559",
"publication_url": "https://clinicaltrials.gov/study/NCT07124559",
"title": "Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419985",
"publication_url": "https://clinicaltrials.gov/study/NCT06419985",
"title": "A Phase 2 Single-arm, Open Label Clinical Trial to Evaluate the Efficacy of Ketamine HCl Prolonged Release Tablets in Participants With Complex Regional Pain Syndrome",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06593418",
"publication_url": "https://clinicaltrials.gov/study/NCT06593418",
"title": "A Phase I/II Study of Cardiac Radioablation for Refractory Ventricular Tachycardia",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011589",
"publication_url": "https://clinicaltrials.gov/study/NCT07011589",
"title": "Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M. Peter Marinkovich",
"sponsor_slug": "m-peter-marinkovich",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209267",
"publication_url": "https://clinicaltrials.gov/study/NCT07209267",
"title": "Baricitinib Curative Repression of HIV-1",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224009",
"publication_url": "https://clinicaltrials.gov/study/NCT07224009",
"title": "Phase II Clinical Trial Evaluating the Safety and Efficacy of Low Dose Naltrexone (LDN) for the Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07541404",
"publication_url": "https://clinicaltrials.gov/study/NCT07541404",
"title": "Pivotal Study of the Treatment of Symptomatic Subacute and Chronic Subdural Hematoma Via Middle Meningeal Artery Embolization With the NeoCastTM Embolic System (RADIANT)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arsenal Medical, Inc.",
"sponsor_slug": "arsenal-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07433673",
"publication_url": "https://clinicaltrials.gov/study/NCT07433673",
"title": "A Phase 2 Single-arm Study of Cemiplimab, Added to Typical Chemotherapy (Gemcitabine, Cisplatin, Nab-paclitaxel) for Down-staging of Locally Advanced, Unresectable Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07551635",
"publication_url": "https://clinicaltrials.gov/study/NCT07551635",
"title": "A Phase 2 Study of SMARCA4/2 Inhibitor (FHD-286) for POU2F3-Positive Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-09-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06816979",
"publication_url": "https://clinicaltrials.gov/study/NCT06816979",
"title": "Assessing the CSF-ctDNA of Patients With Stage III and IV Non-Small Cell Lung Cancer: A Pilot Study",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University Comprehensive Cancer Center",
"sponsor_slug": "ohio-state-university-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07552987",
"publication_url": "https://clinicaltrials.gov/study/NCT07552987",
"title": "A Phase III, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of Intravenous Human Normal Immune Globulin (IGIV) 10% in Adult Patients With Stiff Person Syndrome",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kedrion S.p.A.",
"sponsor_slug": "kedrion-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07644598",
"publication_url": "https://clinicaltrials.gov/study/NCT07644598",
"title": "A Phase II Study of MRI-based Focal Intraprostatic SIB (Simultaneous Integrated Boost) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Georgetown University",
"sponsor_slug": "georgetown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05455996",
"publication_url": "https://clinicaltrials.gov/study/NCT05455996",
"title": "An Open Label Study to Treat Post-Traumatic Stress in Frontline Healthcare Workers and First Responders Using MDMA-Assisted Therapy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nautilus Sanctuary",
"sponsor_slug": "nautilus-sanctuary",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237737",
"publication_url": "https://clinicaltrials.gov/study/NCT07237737",
"title": "Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05179577",
"publication_url": "https://clinicaltrials.gov/study/NCT05179577",
"title": "A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Investigate the Safety and Efficacy of Arbaclofen Extended-Release Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis (Study OS440-3006)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RVL Pharmaceuticals, Inc.",
"sponsor_slug": "rvl-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216586",
"publication_url": "https://clinicaltrials.gov/study/NCT07216586",
"title": "Comparing Opioid Consumption Following Total Knee Arthroplasty With The Perioperative Administration of Zynrelef Versus Adductor Canal Block",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05798754",
"publication_url": "https://clinicaltrials.gov/study/NCT05798754",
"title": "Correlation of Standard Loss of Resistance Technique Versus the CompuFlo®-Assisted Technology for Thoracic Epidural Space Identification",
"has_exemption": false,
"start_date": "2027-04-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "General and Maternity Hospital of Athens Elena Venizelou",
"sponsor_slug": "general-and-maternity-hospital-of-athens-elena-venizelou",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01515527",
"publication_url": "https://clinicaltrials.gov/study/NCT01515527",
"title": "Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)",
"has_exemption": false,
"start_date": "2012-02-07",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04107181",
"publication_url": "https://clinicaltrials.gov/study/NCT04107181",
"title": "A Pilot Study Continuation to Assess the Use of an Introducer \"Calla\" During Cervical Cancer Screening",
"has_exemption": false,
"start_date": "2016-04-14",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02977780",
"publication_url": "https://clinicaltrials.gov/study/NCT02977780",
"title": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
"has_exemption": false,
"start_date": "2017-02-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wen, MD",
"sponsor_slug": "patrick-wen-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03934372",
"publication_url": "https://clinicaltrials.gov/study/NCT03934372",
"title": "An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors in Pediatric Participants",
"has_exemption": false,
"start_date": "2020-01-29",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Biosciences International Sàrl",
"sponsor_slug": "incyte-biosciences-international-sarl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04620187",
"publication_url": "https://clinicaltrials.gov/study/NCT04620187",
"title": "A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas",
"has_exemption": false,
"start_date": "2020-12-24",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05858619",
"publication_url": "https://clinicaltrials.gov/study/NCT05858619",
"title": "Molecular Signatures of Cutaneous Dupilumab Response",
"has_exemption": false,
"start_date": "2023-02-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05039632",
"publication_url": "https://clinicaltrials.gov/study/NCT05039632",
"title": "Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949099",
"publication_url": "https://clinicaltrials.gov/study/NCT05949099",
"title": "Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor",
"has_exemption": false,
"start_date": "2023-08-15",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nam Bui",
"sponsor_slug": "nam-bui",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819853",
"publication_url": "https://clinicaltrials.gov/study/NCT05819853",
"title": "Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05386394",
"publication_url": "https://clinicaltrials.gov/study/NCT05386394",
"title": "Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06127407",
"publication_url": "https://clinicaltrials.gov/study/NCT06127407",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen",
"has_exemption": false,
"start_date": "2024-07-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336655",
"publication_url": "https://clinicaltrials.gov/study/NCT06336655",
"title": "Physiology of Unloading VA ECMO Trial",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617858",
"publication_url": "https://clinicaltrials.gov/study/NCT06617858",
"title": "Open-label Phase 2 Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment",
"has_exemption": false,
"start_date": "2024-12-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645106",
"publication_url": "https://clinicaltrials.gov/study/NCT06645106",
"title": "Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06867549",
"publication_url": "https://clinicaltrials.gov/study/NCT06867549",
"title": "Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940180",
"publication_url": "https://clinicaltrials.gov/study/NCT06940180",
"title": "Perioperative Chemoimmunotherapy With Toripalimab for Sinonasal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Glenn J. Hanna",
"sponsor_slug": "glenn-j-hanna",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05999383",
"publication_url": "https://clinicaltrials.gov/study/NCT05999383",
"title": "Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04433572",
"publication_url": "https://clinicaltrials.gov/study/NCT04433572",
"title": "Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercator MedSystems, Inc.",
"sponsor_slug": "mercator-medsystems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445166",
"publication_url": "https://clinicaltrials.gov/study/NCT06445166",
"title": "A Multicenter Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Adults",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133425",
"publication_url": "https://clinicaltrials.gov/study/NCT07133425",
"title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-11-06",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07085338",
"publication_url": "https://clinicaltrials.gov/study/NCT07085338",
"title": "A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213466",
"publication_url": "https://clinicaltrials.gov/study/NCT07213466",
"title": "Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo",
"has_exemption": false,
"start_date": "2026-01-19",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07636720",
"publication_url": "https://clinicaltrials.gov/study/NCT07636720",
"title": "Sensing in Sleep and Deep Brain Stimulation",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07009899",
"publication_url": "https://clinicaltrials.gov/study/NCT07009899",
"title": "BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461961",
"publication_url": "https://clinicaltrials.gov/study/NCT07461961",
"title": "CORTISHOCK-P: A Randomized Pilot Trial of Corticosteroids as a Pharmacologic Adjunct to Temporary Mechanical Circulatory Support in Inflammation-Enriched Heart Failure Cardiogenic Shock",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477054",
"publication_url": "https://clinicaltrials.gov/study/NCT07477054",
"title": "A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Lungpacer Medical Inc.",
"sponsor_slug": "lungpacer-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441122",
"publication_url": "https://clinicaltrials.gov/study/NCT07441122",
"title": "Building Cognitive Reserve Through Brain-Computer-Interfaces",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02332668",
"publication_url": "https://clinicaltrials.gov/study/NCT02332668",
"title": "A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)",
"has_exemption": false,
"start_date": "2015-03-19",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/study/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205822",
"publication_url": "https://clinicaltrials.gov/study/NCT07205822",
"title": "A Phase IIIb, Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HRpositive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216027",
"publication_url": "https://clinicaltrials.gov/study/NCT07216027",
"title": "A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08049820 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813911",
"publication_url": "https://clinicaltrials.gov/study/NCT06813911",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C and Lp(a)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219407",
"publication_url": "https://clinicaltrials.gov/study/NCT07219407",
"title": "An Open-label, Long-term Study Evaluating RAP-219 in Adult Participants With Refractory Onset Seizures",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223138",
"publication_url": "https://clinicaltrials.gov/study/NCT07223138",
"title": "A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "MoonLake Immunotherapeutics AG",
"sponsor_slug": "moonlake-immunotherapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173924",
"publication_url": "https://clinicaltrials.gov/study/NCT03173924",
"title": "Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2017-06-06",
"completion_date": "2028-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091254",
"publication_url": "https://clinicaltrials.gov/study/NCT06091254",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 Bispecific Antibody Versus Investigator's Choice in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-1)",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03946878",
"publication_url": "https://clinicaltrials.gov/study/NCT03946878",
"title": "An Open Label, Phase II Investigator Initiated Study of Venetoclax and Acalabrutinib in Previously Treated Relapsed/Refractory Patients With Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04771130",
"publication_url": "https://clinicaltrials.gov/study/NCT04771130",
"title": "A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies",
"has_exemption": false,
"start_date": "2021-05-24",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456463",
"publication_url": "https://clinicaltrials.gov/study/NCT06456463",
"title": "A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219043",
"publication_url": "https://clinicaltrials.gov/study/NCT07219043",
"title": "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-02-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525636",
"publication_url": "https://clinicaltrials.gov/study/NCT06525636",
"title": "A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia",
"has_exemption": false,
"start_date": "2024-10-09",
"completion_date": "2028-02-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyowa Kirin Co., Ltd.",
"sponsor_slug": "kyowa-kirin-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516951",
"publication_url": "https://clinicaltrials.gov/study/NCT07516951",
"title": "A Phase IIb, Multicentre, Randomised, Double Blind, Placebo Controlled, Three-arm Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability at Week 24 of 2 Doses of CHF10067 (Zampilimab), With an Optional 24-week Double Blind, Placebo Controlled Extension Phase in Participants With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-02-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708754",
"publication_url": "https://clinicaltrials.gov/study/NCT06708754",
"title": "PBM-LEF Study: The Impact of PBM on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients: A Feasibility Study",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2028-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201066",
"publication_url": "https://clinicaltrials.gov/study/NCT05201066",
"title": "An Open-label, Multicenter, Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.",
"has_exemption": false,
"start_date": "2023-02-13",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581198",
"publication_url": "https://clinicaltrials.gov/study/NCT06581198",
"title": "A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients With Active, Refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN).",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542250",
"publication_url": "https://clinicaltrials.gov/study/NCT06542250",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747585",
"publication_url": "https://clinicaltrials.gov/study/NCT06747585",
"title": "A Phase I/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+Squamous Solid Tumors",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alentis Therapeutics AG",
"sponsor_slug": "alentis-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948448",
"publication_url": "https://clinicaltrials.gov/study/NCT06948448",
"title": "A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo® in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care for First-line Treatment of Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214298",
"publication_url": "https://clinicaltrials.gov/study/NCT07214298",
"title": "A Phase I/II Study of Complement Inhibition in Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415031",
"publication_url": "https://clinicaltrials.gov/study/NCT07415031",
"title": "Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706622",
"publication_url": "https://clinicaltrials.gov/study/NCT06706622",
"title": "Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627244",
"publication_url": "https://clinicaltrials.gov/study/NCT06627244",
"title": "Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007793",
"publication_url": "https://clinicaltrials.gov/study/NCT07007793",
"title": "A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants With Primary Aldosteronism",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03850418",
"publication_url": "https://clinicaltrials.gov/study/NCT03850418",
"title": "Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2019-07-01",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Henry Ford Health System",
"sponsor_slug": "henry-ford-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843434",
"publication_url": "https://clinicaltrials.gov/study/NCT06843434",
"title": "A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06512883",
"publication_url": "https://clinicaltrials.gov/study/NCT06512883",
"title": "Phase 3, Open-label Trial to Evaluate Safety, Pharmacokinetics, and Efficacy of Benralizumab in Children With Eosinophilic Diseases (CLIPS)",
"has_exemption": false,
"start_date": "2025-04-17",
"completion_date": "2028-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947941",
"publication_url": "https://clinicaltrials.gov/study/NCT06947941",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Psychosis Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439485",
"publication_url": "https://clinicaltrials.gov/study/NCT06439485",
"title": "Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244263",
"publication_url": "https://clinicaltrials.gov/study/NCT07244263",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04083495",
"publication_url": "https://clinicaltrials.gov/study/NCT04083495",
"title": "Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma",
"has_exemption": false,
"start_date": "2019-09-17",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06198712",
"publication_url": "https://clinicaltrials.gov/study/NCT06198712",
"title": "A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2023-01-12",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Forma Therapeutics, Inc.",
"sponsor_slug": "forma-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07564414",
"publication_url": "https://clinicaltrials.gov/study/NCT07564414",
"title": "A Clinical Study to Compare Efficacy and Safety of Two Different Doses of CagriSema and Semaglutide in Participants With Obesity With or Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06268873",
"publication_url": "https://clinicaltrials.gov/study/NCT06268873",
"title": "A Phase III, Randomised, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants With CKD and High Blood Pressure",
"has_exemption": false,
"start_date": "2024-03-29",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866405",
"publication_url": "https://clinicaltrials.gov/study/NCT06866405",
"title": "A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744920",
"publication_url": "https://clinicaltrials.gov/study/NCT06744920",
"title": "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06795022",
"publication_url": "https://clinicaltrials.gov/study/NCT06795022",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD9793, a T Cell-engaging Antibody Targeting Glypican-3 (GPC3) in Adult Participants With Advanced or Metastatic Solid Tumours (RHEA-1)",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096908",
"publication_url": "https://clinicaltrials.gov/study/NCT07096908",
"title": "Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Dasman Diabetes Institute",
"sponsor_slug": "dasman-diabetes-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318597",
"publication_url": "https://clinicaltrials.gov/study/NCT07318597",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN13335, an Anti-PDGF-B Monoclonal Antibody, in Adults With Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02162849",
"publication_url": "https://clinicaltrials.gov/study/NCT02162849",
"title": "The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity",
"has_exemption": false,
"start_date": "2015-12-14",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03074812",
"publication_url": "https://clinicaltrials.gov/study/NCT03074812",
"title": "Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03438747",
"publication_url": "https://clinicaltrials.gov/study/NCT03438747",
"title": "An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CeraPedics, Inc",
"sponsor_slug": "cerapedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03586453",
"publication_url": "https://clinicaltrials.gov/study/NCT03586453",
"title": "A Phase II Study of Osimertinib With On-study and Post-progression Biopsy in the First Line Treatment of EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer",
"has_exemption": false,
"start_date": "2018-08-13",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887715",
"publication_url": "https://clinicaltrials.gov/study/NCT03887715",
"title": "A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LivaNova",
"sponsor_slug": "livanova",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03282396",
"publication_url": "https://clinicaltrials.gov/study/NCT03282396",
"title": "Phase II Trial of Ibrutinib in Perviously Untreated High Risk Smoldering Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2020-06-08",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04610866",
"publication_url": "https://clinicaltrials.gov/study/NCT04610866",
"title": "Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04380545",
"publication_url": "https://clinicaltrials.gov/study/NCT04380545",
"title": "A Phase I/II Study of Nivolumab Plus 5-Fluorouracil Plus Interferon-α2b for Unresectable Fibrolamellar Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2021-01-13",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04931342",
"publication_url": "https://clinicaltrials.gov/study/NCT04931342",
"title": "A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04712539",
"publication_url": "https://clinicaltrials.gov/study/NCT04712539",
"title": "Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05037760",
"publication_url": "https://clinicaltrials.gov/study/NCT05037760",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination With Ruxolitinib in Participants With Myelofibrosis",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064280",
"publication_url": "https://clinicaltrials.gov/study/NCT05064280",
"title": "Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases",
"has_exemption": false,
"start_date": "2022-01-20",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04966481",
"publication_url": "https://clinicaltrials.gov/study/NCT04966481",
"title": "Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor: A Multicenter, Open-Label, Randomized Phase 3 Trial",
"has_exemption": false,
"start_date": "2022-04-06",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05594992",
"publication_url": "https://clinicaltrials.gov/study/NCT05594992",
"title": "An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects",
"has_exemption": false,
"start_date": "2023-02-22",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "JCR Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jcr-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05816382",
"publication_url": "https://clinicaltrials.gov/study/NCT05816382",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05546554",
"publication_url": "https://clinicaltrials.gov/study/NCT05546554",
"title": "Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06331052",
"publication_url": "https://clinicaltrials.gov/study/NCT06331052",
"title": "3-D Tractography Focused Ultrasound Ablation for Essential Tremor",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987644",
"publication_url": "https://clinicaltrials.gov/study/NCT05987644",
"title": "DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Joshua Palmer",
"sponsor_slug": "joshua-palmer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564038",
"publication_url": "https://clinicaltrials.gov/study/NCT06564038",
"title": "A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination With Other Anticancer Agents in Participants With Mature B-Cell Malignancies",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964269",
"publication_url": "https://clinicaltrials.gov/study/NCT06964269",
"title": "A Phase 4 Pilot Study With Extension to Assess the Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease and the Effect on Corneal Nerves and Neuropathic Corneal Pain",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Toyos Clinic",
"sponsor_slug": "toyos-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831149",
"publication_url": "https://clinicaltrials.gov/study/NCT06831149",
"title": "A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Spector",
"sponsor_slug": "matthew-spector",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855498",
"publication_url": "https://clinicaltrials.gov/study/NCT06855498",
"title": "A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810375",
"publication_url": "https://clinicaltrials.gov/study/NCT06810375",
"title": "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819670",
"publication_url": "https://clinicaltrials.gov/study/NCT06819670",
"title": "A Multicenter Pilot Clinical Trial to Prevent Infantile Spasms Relapse",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218679",
"publication_url": "https://clinicaltrials.gov/study/NCT07218679",
"title": "Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla",
"sponsor_slug": "fundacion-publica-andaluza-para-la-gestion-de-la-investigacion-en-sevilla",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817018",
"publication_url": "https://clinicaltrials.gov/study/NCT06817018",
"title": "Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Shen",
"sponsor_slug": "leslie-shen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07048262",
"publication_url": "https://clinicaltrials.gov/study/NCT07048262",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 Years) With Non-cystic Fibrosis Bronchiectasis",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284875",
"publication_url": "https://clinicaltrials.gov/study/NCT07284875",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287917",
"publication_url": "https://clinicaltrials.gov/study/NCT07287917",
"title": "A Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination With Standard of Care in Patients With Advanced Solid Tumors Who Progressed After Prior Therapies",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Aminex Therapeutics, Inc.",
"sponsor_slug": "aminex-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704100",
"publication_url": "https://clinicaltrials.gov/study/NCT06704100",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07598396",
"publication_url": "https://clinicaltrials.gov/study/NCT07598396",
"title": "A Phase II Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Mosunetuzumab in Patients With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-05-25",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06674109",
"publication_url": "https://clinicaltrials.gov/study/NCT06674109",
"title": "SAVE-Care (SGLT2i As Novel Gout Care) Trial",
"has_exemption": false,
"start_date": "2026-05-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948084",
"publication_url": "https://clinicaltrials.gov/study/NCT06948084",
"title": "A Randomized Phase II Trial for High-Risk Multiple Myeloma That is Refractory or in First Relapse With Daratumumab, Teclistamab (DT) Versus Daratumumab, Pomalidomide, Dexamethasone (DPd) or Daratumumab, Carfilzomib, Dexamethasone (DKd)",
"has_exemption": false,
"start_date": "2026-08-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07568535",
"publication_url": "https://clinicaltrials.gov/study/NCT07568535",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Mesoblast, Ltd.",
"sponsor_slug": "mesoblast-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833206",
"publication_url": "https://clinicaltrials.gov/study/NCT03833206",
"title": "A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients: Part I Dose Escalation",
"has_exemption": false,
"start_date": "2027-01-15",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "BioLite, Inc.",
"sponsor_slug": "biolite-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593456",
"publication_url": "https://clinicaltrials.gov/study/NCT07593456",
"title": "Investigating a Gamified NegatIve-symptom Therapeutic Based on Evidence-based Cognitive Therapy (IGNITE)",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "North Shore Therapeutics, Inc.",
"sponsor_slug": "north-shore-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02679144",
"publication_url": "https://clinicaltrials.gov/study/NCT02679144",
"title": "NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03093116",
"publication_url": "https://clinicaltrials.gov/study/NCT03093116",
"title": "A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)",
"has_exemption": false,
"start_date": "2017-03-07",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Turning Point Therapeutics, Inc.",
"sponsor_slug": "turning-point-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04524611",
"publication_url": "https://clinicaltrials.gov/study/NCT04524611",
"title": "A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337580",
"publication_url": "https://clinicaltrials.gov/study/NCT04337580",
"title": "A Phase II Trial of FASN Inhibition by Omeprazole in Combination With Cabazitaxel in Patients With Docetaxel- and Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04779554",
"publication_url": "https://clinicaltrials.gov/study/NCT04779554",
"title": "A Randomized Phase 2 Trial of Flat Dose vs. Weight-based Dose of Intra-peritoneal (IP) Chemotherapy for Patients Undergoing Cytoreductive Surgery and Heated Intra-peritoneal Chemotherapy (CRS/HIPEC) for Advanced Gastrointestinal Malignancy",
"has_exemption": false,
"start_date": "2021-06-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Prakash Pandalai",
"sponsor_slug": "prakash-pandalai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130450",
"publication_url": "https://clinicaltrials.gov/study/NCT05130450",
"title": "An Open-Label Extension Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)",
"has_exemption": false,
"start_date": "2021-11-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04704505",
"publication_url": "https://clinicaltrials.gov/study/NCT04704505",
"title": "Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD Study)",
"has_exemption": false,
"start_date": "2022-04-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05456880",
"publication_url": "https://clinicaltrials.gov/study/NCT05456880",
"title": "A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients With Sickle Cell Disease and Severe Vaso-Occlusive Crises (Beacon Trial)",
"has_exemption": false,
"start_date": "2022-08-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Beam Therapeutics Inc.",
"sponsor_slug": "beam-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05529316",
"publication_url": "https://clinicaltrials.gov/study/NCT05529316",
"title": "A Multicohort, Open Label, Phase 2 Study of Botensilimab (AGEN1181) for Treatment of Advanced Melanoma Refractory to Prior Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Agenus Inc.",
"sponsor_slug": "agenus-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905914",
"publication_url": "https://clinicaltrials.gov/study/NCT04905914",
"title": "A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of Oral ATRN-119 In Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-01-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Aprea Therapeutics",
"sponsor_slug": "aprea-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05573126",
"publication_url": "https://clinicaltrials.gov/study/NCT05573126",
"title": "A Modular, Open-Label, Multi-Centre Phase 1/2 Dose-Finding, Optimisation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0062 as Monotherapy and in Combination in Patients With Relapsed Locally Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer",
"has_exemption": false,
"start_date": "2023-01-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellipses Pharma",
"sponsor_slug": "ellipses-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05783609",
"publication_url": "https://clinicaltrials.gov/study/NCT05783609",
"title": "A Phase 2 Study of Epcoritamab and Rituximab for First-line Treatment of Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05537896",
"publication_url": "https://clinicaltrials.gov/study/NCT05537896",
"title": "Prospective Evaluation of Xerava™ (Eravacycline) Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260709",
"publication_url": "https://clinicaltrials.gov/study/NCT06260709",
"title": "Open-label Extension Study of Long-term Safety and Efficacy of NNC6019-0001 in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR CM)",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161025",
"publication_url": "https://clinicaltrials.gov/study/NCT06161025",
"title": "A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2024-02-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05913388",
"publication_url": "https://clinicaltrials.gov/study/NCT05913388",
"title": "Randomized Double-Blind Placebo Controlled Phase II Study of a Galectin-3 Inhibitor (GB1211) and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191562",
"publication_url": "https://clinicaltrials.gov/study/NCT06191562",
"title": "Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "David Chi, MD",
"sponsor_slug": "david-chi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158854",
"publication_url": "https://clinicaltrials.gov/study/NCT06158854",
"title": "An Open-Label Phase 1/2 Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111781",
"publication_url": "https://clinicaltrials.gov/study/NCT06111781",
"title": "The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384807",
"publication_url": "https://clinicaltrials.gov/study/NCT06384807",
"title": "A Phase 1/2, First in Human, Dose Escalation and Dose Expansion Study of BHV-1510 (Previously PBI-410) as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681195",
"publication_url": "https://clinicaltrials.gov/study/NCT05681195",
"title": "Zanubrutinib With Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial With a Safety Lead-In",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504147",
"publication_url": "https://clinicaltrials.gov/study/NCT06504147",
"title": "A Phase 2, Randomised, Open Label, Multicentre Study of an Intraperitoneal α-emitting Radionuclide Therapy (Radspherin®) in Patients With Primary Advanced High-grade Serous or High-grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient and Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery",
"has_exemption": false,
"start_date": "2024-06-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oncoinvent Solutions AS",
"sponsor_slug": "oncoinvent-solutions-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496178",
"publication_url": "https://clinicaltrials.gov/study/NCT06496178",
"title": "A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus B.V.",
"sponsor_slug": "merus-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06437574",
"publication_url": "https://clinicaltrials.gov/study/NCT06437574",
"title": "Lowering Cholesterol in Prostate Cancer to Target Rapamycin-Insensitive Companion Of MTOR (TORC2) in T-Cell Surface Glycoprotein CD8 Alpha Chain (CD8+) Lymphocytes",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06388083",
"publication_url": "https://clinicaltrials.gov/study/NCT06388083",
"title": "A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Belite Bio, Inc",
"sponsor_slug": "belite-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455787",
"publication_url": "https://clinicaltrials.gov/study/NCT06455787",
"title": "J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "JC Medical, Inc., an affiliate of Edwards Lifesciences LLC",
"sponsor_slug": "jc-medical-inc-an-affiliate-of-edwards-lifesciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310031",
"publication_url": "https://clinicaltrials.gov/study/NCT06310031",
"title": "Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BrioHealth Solutions, Inc.",
"sponsor_slug": "briohealth-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336798",
"publication_url": "https://clinicaltrials.gov/study/NCT06336798",
"title": "Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568939",
"publication_url": "https://clinicaltrials.gov/study/NCT06568939",
"title": "A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092333",
"publication_url": "https://clinicaltrials.gov/study/NCT06092333",
"title": "A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699602",
"publication_url": "https://clinicaltrials.gov/study/NCT06699602",
"title": "A Pilot Phase II Study of Neoadjuvant Cemiplimab + Fianlimab in Patients With Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534060",
"publication_url": "https://clinicaltrials.gov/study/NCT06534060",
"title": "A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).",
"has_exemption": false,
"start_date": "2025-02-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "March Biosciences Inc",
"sponsor_slug": "march-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902311",
"publication_url": "https://clinicaltrials.gov/study/NCT06902311",
"title": "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824792",
"publication_url": "https://clinicaltrials.gov/study/NCT06824792",
"title": "Real-world Study to Investigate Optimal Standard Treatment Selection for Solid Tumor Patients by Guided by Biologically-informed Multi-agent System",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "NING LI",
"sponsor_slug": "ning-li",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06522737",
"publication_url": "https://clinicaltrials.gov/study/NCT06522737",
"title": "A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SecuraBio",
"sponsor_slug": "securabio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730283",
"publication_url": "https://clinicaltrials.gov/study/NCT05730283",
"title": "Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Non-Tuberculous Mycobacterium Disease",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Winthrop",
"sponsor_slug": "kevin-winthrop",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995677",
"publication_url": "https://clinicaltrials.gov/study/NCT06995677",
"title": "A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801639",
"publication_url": "https://clinicaltrials.gov/study/NCT06801639",
"title": "Advancing Alzheimer's Care: Home-based tDCS (Transcranial Direct Current Stimulator) for Affective Symptoms",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055594",
"publication_url": "https://clinicaltrials.gov/study/NCT07055594",
"title": "A Phase I/IIa Dose-escalation, Dose-optimization and Dose Expansion Study to Evaluate the Safety and Preliminary Efficacy of Tri-specific Antibody (SOA101) in Subjects With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Shine-On Biomedical Co., Ltd.",
"sponsor_slug": "shine-on-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145918",
"publication_url": "https://clinicaltrials.gov/study/NCT07145918",
"title": "An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029581",
"publication_url": "https://clinicaltrials.gov/study/NCT07029581",
"title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070232",
"publication_url": "https://clinicaltrials.gov/study/NCT07070232",
"title": "A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925321",
"publication_url": "https://clinicaltrials.gov/study/NCT06925321",
"title": "An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955728",
"publication_url": "https://clinicaltrials.gov/study/NCT06955728",
"title": "A Phase-IIIb Individually Randomized, Placebo-controlled Trial on Safety of RSVA/B-preF Vaccine in Pregnant Women and Efficacy Against Severe RSV-associated Lower Respiratory Tract Infection in Infants",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Witwatersrand, South Africa",
"sponsor_slug": "university-of-witwatersrand-south-africa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521476",
"publication_url": "https://clinicaltrials.gov/study/NCT06521476",
"title": "Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanjay R Patel",
"sponsor_slug": "sanjay-r-patel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800963",
"publication_url": "https://clinicaltrials.gov/study/NCT06800963",
"title": "ResQ133A-NMIBC: Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221851",
"publication_url": "https://clinicaltrials.gov/study/NCT07221851",
"title": "A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma A/S",
"sponsor_slug": "ascendis-pharma-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288320",
"publication_url": "https://clinicaltrials.gov/study/NCT07288320",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder Who Are Currently Experiencing a Manic Episode or Manic Episode With Mixed Features, With or Without Psychotic Symptoms, and Warrant Inpatient Hospitalization",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201519",
"publication_url": "https://clinicaltrials.gov/study/NCT07201519",
"title": "Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J Cavnar, MD",
"sponsor_slug": "michael-j-cavnar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07494305",
"publication_url": "https://clinicaltrials.gov/study/NCT07494305",
"title": "A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With Major Depressive Episodes Associated With Bipolar I Disorder",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "LB Pharmaceuticals Inc.",
"sponsor_slug": "lb-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412756",
"publication_url": "https://clinicaltrials.gov/study/NCT07412756",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Major Depressive Disorder (RENEW-MDD 1)",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285005",
"publication_url": "https://clinicaltrials.gov/study/NCT07285005",
"title": "A Phase 3, Randomized, Parallel, Multicenter, Double-blind, Placebo-controlled Study to Investigate Efficacy and Safety of KP 001 in Patients Aged ≥2 Years With Common Venous Malformations, Common Lymphatic Malformations, or KTS/CLOVES Syndrome",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kaken Pharmaceutical",
"sponsor_slug": "kaken-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192731",
"publication_url": "https://clinicaltrials.gov/study/NCT07192731",
"title": "Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191548",
"publication_url": "https://clinicaltrials.gov/study/NCT07191548",
"title": "Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study.",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07404111",
"publication_url": "https://clinicaltrials.gov/study/NCT07404111",
"title": "An Adaptive Phase 1/2 MulticenteR Study Evaluating the Safety, Tolerability, Pharmacokinetics and EfficaCy of VV-14305 Delivered Via PeribuLbAr Injection in Patients With Moderate to Severe Thyroid Eye Disease (the RECLAIM Study)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kriya Therapeutics, Inc.",
"sponsor_slug": "kriya-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434635",
"publication_url": "https://clinicaltrials.gov/study/NCT07434635",
"title": "APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07355231",
"publication_url": "https://clinicaltrials.gov/study/NCT07355231",
"title": "Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Xemed LLC",
"sponsor_slug": "xemed-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07492160",
"publication_url": "https://clinicaltrials.gov/study/NCT07492160",
"title": "Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms After 12-18 Week Abortion or Pregnancy Loss: A Pilot and Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Maimonides Medical Center",
"sponsor_slug": "maimonides-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07382674",
"publication_url": "https://clinicaltrials.gov/study/NCT07382674",
"title": "Zesty Exercise System for Therapeutic Engagement",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318584",
"publication_url": "https://clinicaltrials.gov/study/NCT07318584",
"title": "Cefotetan Therapy for Escherichia Coli Bacteremia and Genitourinary Infections: a Prospective Phase II Pilot Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416604",
"publication_url": "https://clinicaltrials.gov/study/NCT07416604",
"title": "A Multicenter, Randomized, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of NXT007 Prophylaxis Versus Emicizumab Prophylaxis in People With Hemophilia A",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429110",
"publication_url": "https://clinicaltrials.gov/study/NCT07429110",
"title": "ColoSeal™ ICD System Anastomotic Protection Pivotal Study",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Averto Medical, Inc.",
"sponsor_slug": "averto-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226063",
"publication_url": "https://clinicaltrials.gov/study/NCT07226063",
"title": "A Phase II Study of Maintenance Zanzalintinib and Durvalumab in Patients With Advanced Hepatocellular Cancer After Induction Tremelimumab Plus Durvalumab",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amit Mahipal",
"sponsor_slug": "amit-mahipal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428616",
"publication_url": "https://clinicaltrials.gov/study/NCT07428616",
"title": "A Phase 2, Single-Arm, Multicenter, Open-Label Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286331",
"publication_url": "https://clinicaltrials.gov/study/NCT07286331",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy",
"has_exemption": false,
"start_date": "2026-06-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07488988",
"publication_url": "https://clinicaltrials.gov/study/NCT07488988",
"title": "SCARFREE-001: A Phase 2 Dose-Finding and Proof-of-Concept Study of Intradermal Verteporfin for Scar Prevention in Open and Closed Surgical Wounds",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Odense University Hospital",
"sponsor_slug": "odense-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07534709",
"publication_url": "https://clinicaltrials.gov/study/NCT07534709",
"title": "Suzetrigine Versus Placebo for Opioid-Free Recovery After Cesarean Delivery: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07621237",
"publication_url": "https://clinicaltrials.gov/study/NCT07621237",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tonix Pharmaceuticals, Inc.",
"sponsor_slug": "tonix-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465718",
"publication_url": "https://clinicaltrials.gov/study/NCT07465718",
"title": "Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Orphalan",
"sponsor_slug": "orphalan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907485",
"publication_url": "https://clinicaltrials.gov/study/NCT06907485",
"title": "A Multicenter Study to Assess the Feasibility of Gleolan (ALA / Aminolevulinic Acid HCl) in Pediatric Brain Tumor Patients After Delayed Administration",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Costas Hadjipanayis",
"sponsor_slug": "costas-hadjipanayis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428681",
"publication_url": "https://clinicaltrials.gov/study/NCT07428681",
"title": "Preventive Administration of Lorazepam in Critically Ill Patients With High Anttila-Index to Reduce the Incidence of Intensive Care Delirium: a Single-centre, Randomized, Controlled Clinical Trial - the Basel LOC2DEL-Trial",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Basel, Switzerland",
"sponsor_slug": "university-hospital-basel-switzerland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114679",
"publication_url": "https://clinicaltrials.gov/study/NCT07114679",
"title": "Molecular Breast Imaging (MBI)-Guided Biopsy Pilot SBIR",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Smart Breast Corp.",
"sponsor_slug": "smart-breast-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02991469",
"publication_url": "https://clinicaltrials.gov/study/NCT02991469",
"title": "An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, With Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase",
"has_exemption": false,
"start_date": "2018-08-09",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404088",
"publication_url": "https://clinicaltrials.gov/study/NCT04404088",
"title": "A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560322",
"publication_url": "https://clinicaltrials.gov/study/NCT04560322",
"title": "A Phase 2 Study of MRD Adapted Therapy With Venetoclax-obinutuzumab in Patients With High or Intermediate BALL Risk Relapsed or Refractory CLL, With Addition of Acalabrutinib in Patients Who Fail to Achieve MRD Eradication",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747912",
"publication_url": "https://clinicaltrials.gov/study/NCT04747912",
"title": "A Phase II Study of a Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia (ALL) Incorporating Inotuzumab Ozogamicin (InO)",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04394858",
"publication_url": "https://clinicaltrials.gov/study/NCT04394858",
"title": "A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma",
"has_exemption": false,
"start_date": "2021-03-17",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871139",
"publication_url": "https://clinicaltrials.gov/study/NCT04871139",
"title": "Contrast-Enhanced Mammography (CEM) for the Evaluation and Targeted Biopsy of Suspicious Mammographic Architectural Distortions",
"has_exemption": false,
"start_date": "2021-04-08",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04826341",
"publication_url": "https://clinicaltrials.gov/study/NCT04826341",
"title": "A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04941274",
"publication_url": "https://clinicaltrials.gov/study/NCT04941274",
"title": "A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05488431",
"publication_url": "https://clinicaltrials.gov/study/NCT05488431",
"title": "Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Priscilla Hsue, MD",
"sponsor_slug": "priscilla-hsue-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05727904",
"publication_url": "https://clinicaltrials.gov/study/NCT05727904",
"title": "A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05706025",
"publication_url": "https://clinicaltrials.gov/study/NCT05706025",
"title": "Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097468",
"publication_url": "https://clinicaltrials.gov/study/NCT06097468",
"title": "A Phase I/IIa, Single-Arm, Dose-Confirmation and Dose-Expansion Study Evaluating Changes in the Oral Microbiome of Patients With Oral Cavity Squamous Cell Carcinoma (OSCC) After Short-Term Ingestion of Nisin, a Naturally Occurring Food Preservative",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}